Status:
COMPLETED
Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia
Lead Sponsor:
Basilea Pharmaceutica
Conditions:
Pneumonia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the clinical cure rate (ratio of clinically cured patients to the total number of patients) of ceftobiprole medocaril versus a comparator in the treatment of pa...
Detailed Description
Ceftobiprole medocaril is a cephalosporin antibiotic with anti-MRSA (Methicillin-Resistant Staphylococcus Aureus) activity. Ceftobiprole medocaril is not yet approved for the treatment of community-ac...
Eligibility Criteria
Inclusion
- Patients suffering from community-acquired pneumonia severe enough to require hospitalization
- Female patients must be postmenopausal for at least 1 year, surgically sterile, or practicing an effective method of birth control before entry and throughout the study
Exclusion
- Patients with known or suspected hypersensitivity to any related antibiotic medications
- Treatment with any experimental drug within 30 days before enrollment
- Prior enrollment in this study or any study with ceftobiprole medocaril
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
638 Patients enrolled
Trial Details
Trial ID
NCT00326287
Start Date
June 1 2006
End Date
July 1 2007
Last Update
August 2 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.